BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11223026)

  • 1. Pathways governing G1/S transition and their response to DNA damage.
    Bartek J; Lukas J
    FEBS Lett; 2001 Feb; 490(3):117-22. PubMed ID: 11223026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
    Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
    Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
    Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
    Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Lundberg AS; Weinberg RA
    Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.
    Bash J; Zong WX; GĂ©linas C
    Mol Cell Biol; 1997 Nov; 17(11):6526-36. PubMed ID: 9343416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
    Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
    Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
    Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
    Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of S phase by G1 regulatory factors.
    Kato J
    Front Biosci; 1999 Dec; 4():D787-92. PubMed ID: 10577389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein.
    Obeyesekere MN; Herbert JR; Zimmerman SO
    Oncogene; 1995 Sep; 11(6):1199-205. PubMed ID: 7566981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.